Habib AA, Zhao C, Aban I, Franca MC Jr, et al. Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial. Lancet Neurol 2025;24:117-127.
PMID: 39862880